Crystal Denlinger, Chief Executive Officer at National Comprehensive Cancer Network, made the following post on LinkedIn:
“NCCN Global Academy for Excellence and Leadership in Oncology panelists from academia, industry, and patient advocacy discuss the importance of including patients in the cancer research development process, overcoming barriers across the globe including LMICs, determining value of therapies, and ensuring access to therapies of value to patients.”
Source: Crystal Denlinger/LinkedIn